Oramed Pharmaceuticals Inc. (ORMP) News Nov 20, 20
Post# of 250601
Posted On: 11/20/2014 10:57:03 PM
Oramed Pharmaceuticals Inc. (ORMP) News Nov 20, 2014, 3:58 p.m.
MarketWatch News on ORMP
Oramed's oral insulin tests are positive, but investors are skittish 2:17 p.m. Jan. 30, 2014 - Russ Britt
Twitter, Tesla surge; BlackBerry slips 4:22 p.m. Dec. 26, 2013 - Wallace Witkowski
Oramed gets FDA approval for flagship drug plans 9:04 a.m. May 17, 2013 - MarketWatch.com
Other News on ORMP
10-K: ORAMED PHARMACEUTICALS INC. 10:10 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 7:12 a.m. Oct. 3, 2014 - Seeking Alpha
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 1:15 p.m. Sept. 14, 2014 - Seeking Alpha
10-Q: ORAMED PHARMACEUTICALS INC. 2:40 p.m. July 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Traders taking positions ahead of Oramed's presentations 3:03 p.m. June 11, 2014 - Seeking Alpha
The Importance Of Being Oral 5:32 p.m. June 3, 2014 - Seeking Alpha
Does Oramed Pharmaceuticals Pass The Smell Test? 11:06 a.m. May 23, 2014 - Seeking Alpha
10-Q: ORAMED PHARMACEUTICALS INC. 1:42 p.m. April 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs 10:01 a.m. April 8, 2014 - Seeking Alpha
Oramed gets roughed up 12:16 p.m. March 12, 2014 - Seeking Alpha
Shots fired at Oramed in NY Observer 12:11 p.m. Feb. 26, 2014 - Seeking Alpha
Oramed submits phase 2a protocol to FDA for diabetes treatment, +14% 3:29 p.m. Feb. 10, 2014 - Seeking Alpha
The Dream Of The Insulin Pill: Oramed Vs. Rivals 6:51 a.m. Feb. 6, 2014 - Seeking Alpha
Oramed sinks after trial results criticized 10:13 a.m. Feb. 3, 2014 - Seeking Alpha
Oramed insulin capsule hits trial goals 7:16 a.m. Jan. 30, 2014 - Seeking Alpha
Oramed's Data Will Define A New Standard For Diabetes 7:48 a.m. Jan. 28, 2014 - Seeking Alpha
3 Small Biotech Companies Poised For Big Growth In 2014 1:07 p.m. Jan. 21, 2014 - Seeking Alpha
Six Israeli Biotech New Issues Set A Blistering Pace 5:12 p.m. Jan. 14, 2014 - Investors Business Daily
10-Q: ORAMED PHARMACEUTICALS INC. 3:35 p.m. Jan. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aegis sees further upside for Oramed after big run 11:02 a.m. Jan. 8, 2014 - Seeking Alpha
Press Releases on ORMP
Coverage Initiation Report Focuses on Oramed Pharmaceuticals 8:46 a.m. Nov. 11, 2014 - Marketwired
Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 7:25 a.m. Oct. 31, 2014 - PR Newswire - PRF
Oramed to Present at the FireRock Annual Micro-Cap Conference 7:25 a.m. Oct. 24, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 7:29 a.m. Oct. 22, 2014 - PR Newswire - PRF
Oramed to Present at Family Office & Wealth Management Conference 7:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Oramed's Insulin Pill Superior to New Diabetes Drugs Gaining Approval 7:01 a.m. Sept. 11, 2014 - ACCESSWIRE
Oramed to Present at Upcoming Conferences 7:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Oramed Granted Patent in Spain for Oral Administration of Insulin 7:15 a.m. Aug. 19, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Reports Last Patient Out in Phase IIa Trial for ORMD-0801 in Type 1 Diabetes 7:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 2:31 p.m. July 15, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego 7:15 a.m. June 23, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 - 17, 2014 in San Francisco 7:15 a.m. June 10, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index 11:00 a.m. May 29, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the IATI Israel Innovation Conference in Tel Aviv 6:00 a.m. May 19, 2014 - PR Newswire - PRF
Oramed to Present Poster on its Oral Insulin Capsule at the Yale Diabetes Symposium 12:10 p.m. May 13, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit 1:30 p.m. April 24, 2014 - PR Newswire - PRF
Oramed Granted Patent in Hong Kong for Oral Administration of Insulin 7:10 a.m. April 10, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes 7:45 a.m. March 27, 2014 - PR Newswire - PRF
LifeSci Advisors Initiates Coverage of Oramed Pharmaceuticals 8:31 a.m. March 20, 2014 - Marketwire
Oramed Granted its 3rd Patent in Australia for Oral Administration of Exenatide 7:30 a.m. March 11, 2014 - PR Newswire - PRF
MarketWatch News on ORMP
Oramed's oral insulin tests are positive, but investors are skittish 2:17 p.m. Jan. 30, 2014 - Russ Britt
Twitter, Tesla surge; BlackBerry slips 4:22 p.m. Dec. 26, 2013 - Wallace Witkowski
Oramed gets FDA approval for flagship drug plans 9:04 a.m. May 17, 2013 - MarketWatch.com
Other News on ORMP
10-K: ORAMED PHARMACEUTICALS INC. 10:10 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 7:12 a.m. Oct. 3, 2014 - Seeking Alpha
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 1:15 p.m. Sept. 14, 2014 - Seeking Alpha
10-Q: ORAMED PHARMACEUTICALS INC. 2:40 p.m. July 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Traders taking positions ahead of Oramed's presentations 3:03 p.m. June 11, 2014 - Seeking Alpha
The Importance Of Being Oral 5:32 p.m. June 3, 2014 - Seeking Alpha
Does Oramed Pharmaceuticals Pass The Smell Test? 11:06 a.m. May 23, 2014 - Seeking Alpha
10-Q: ORAMED PHARMACEUTICALS INC. 1:42 p.m. April 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs 10:01 a.m. April 8, 2014 - Seeking Alpha
Oramed gets roughed up 12:16 p.m. March 12, 2014 - Seeking Alpha
Shots fired at Oramed in NY Observer 12:11 p.m. Feb. 26, 2014 - Seeking Alpha
Oramed submits phase 2a protocol to FDA for diabetes treatment, +14% 3:29 p.m. Feb. 10, 2014 - Seeking Alpha
The Dream Of The Insulin Pill: Oramed Vs. Rivals 6:51 a.m. Feb. 6, 2014 - Seeking Alpha
Oramed sinks after trial results criticized 10:13 a.m. Feb. 3, 2014 - Seeking Alpha
Oramed insulin capsule hits trial goals 7:16 a.m. Jan. 30, 2014 - Seeking Alpha
Oramed's Data Will Define A New Standard For Diabetes 7:48 a.m. Jan. 28, 2014 - Seeking Alpha
3 Small Biotech Companies Poised For Big Growth In 2014 1:07 p.m. Jan. 21, 2014 - Seeking Alpha
Six Israeli Biotech New Issues Set A Blistering Pace 5:12 p.m. Jan. 14, 2014 - Investors Business Daily
10-Q: ORAMED PHARMACEUTICALS INC. 3:35 p.m. Jan. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aegis sees further upside for Oramed after big run 11:02 a.m. Jan. 8, 2014 - Seeking Alpha
Press Releases on ORMP
Coverage Initiation Report Focuses on Oramed Pharmaceuticals 8:46 a.m. Nov. 11, 2014 - Marketwired
Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 7:25 a.m. Oct. 31, 2014 - PR Newswire - PRF
Oramed to Present at the FireRock Annual Micro-Cap Conference 7:25 a.m. Oct. 24, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 7:29 a.m. Oct. 22, 2014 - PR Newswire - PRF
Oramed to Present at Family Office & Wealth Management Conference 7:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Oramed's Insulin Pill Superior to New Diabetes Drugs Gaining Approval 7:01 a.m. Sept. 11, 2014 - ACCESSWIRE
Oramed to Present at Upcoming Conferences 7:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Oramed Granted Patent in Spain for Oral Administration of Insulin 7:15 a.m. Aug. 19, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Reports Last Patient Out in Phase IIa Trial for ORMD-0801 in Type 1 Diabetes 7:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 2:31 p.m. July 15, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego 7:15 a.m. June 23, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 - 17, 2014 in San Francisco 7:15 a.m. June 10, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index 11:00 a.m. May 29, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the IATI Israel Innovation Conference in Tel Aviv 6:00 a.m. May 19, 2014 - PR Newswire - PRF
Oramed to Present Poster on its Oral Insulin Capsule at the Yale Diabetes Symposium 12:10 p.m. May 13, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit 1:30 p.m. April 24, 2014 - PR Newswire - PRF
Oramed Granted Patent in Hong Kong for Oral Administration of Insulin 7:10 a.m. April 10, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes 7:45 a.m. March 27, 2014 - PR Newswire - PRF
LifeSci Advisors Initiates Coverage of Oramed Pharmaceuticals 8:31 a.m. March 20, 2014 - Marketwire
Oramed Granted its 3rd Patent in Australia for Oral Administration of Exenatide 7:30 a.m. March 11, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼